Description & Objectives

Description & Objectives

Target Audience

This course is intended for neurologists, pain physicians, primary-care physicians and advanced care practitioners who care for patients with chronic neurological disorders in Washington, Oregon, Idaho, Montana and Alaska.

Needs Statement

As advocates for their patients, clinicians have identified the need to know when it is appropriate to consider alternative neuromodulative therapies such as deep brain stimulation for movement disorders and pain. By educating physicians and other health care professionals about the appropriate use of neuromodulative therapies, the quality of life will improve for this rapidly increasing patient population, their families and their caregivers. This will ultimately enrich the physical, emotional and social well-being of our communities.  

This symposium will explore current techniques and indications for interacting with the nervous system to help patients with neurological diseases. This is a very exciting area with new indications emerging all the time, which give or that give rise to both technical and ethical challenges regarding what can or should be done to enhance neurological function.

Course Objectives

At the conclusion of this symposium, the participant will provide better patient care through an increased ability to:

  • Review results from the NeuroPace study and discuss case selection and programming
  • Describe three types of surgical resection for temporal lobe epilepsy (TLE), explain selective microsurgical amygdalohippocampectomy and discuss resection of cortical dysplasia for epilepsy
  • Discuss the complexity of pre-surgical evaluation in epilepsy patients, outline the steps in the evaluation of an intractable epilepsy patient and describe the importance of vascular endothelial growth factor (VEGF) in decision making for the surgeon
  • Address the debate between anatomical and electrophysiological targeting, discuss the current place of deep brain stimulation (DBS) in the management of Parkinson's disease and describe the role of intraoperative imaging in functional neurosurgery
  • Compare globus pallidus interus (GPi) and subthalamic nucleus (STN), discuss selecting a target and review programming when treating patients with Parkinson's disease
  • Explain the main rationales for using gene therapy for Parkinson's disease, describe proposed mechanisms of action of gene therapy approaches and discuss data on safety and efficacy for gene therapy approaches
  • Discuss a complex case of Parkinson's disease and the approaches for treatment management
  • Differentiate between the tremor of Parkinson's disease and Essential Tremor, discuss the different brain targets to treat tremor and outline the surgical technique for DBS in the thalamus
  • Review the history of Gamma Knife's treatment of Essential Tremor, explain patient selection criteria for Gamma Knife treatment of Essential Tremor and discuss success rates and complication rates for Gamma Knife treatment of Essential Tremor
  • List indications for treatment of Essential Tremor with focused ultrasound (FUS), describe how FUS can be used to create a lesion in the brain and outline the results of the pilot study on FUS for Essential Tremor
  • Describe a clinical case illustrating the factors involved in deciding if and when surgical intervention is indicated for Essential Tremor and decide how to choose the most appropriate type of intervention
  • Discuss the current theory and research on DBS for treatment resistant depression and describe the brain circuits that underlie normal and abnormal mood states
  • Describe the mechanisms of action of Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS), list the indications for interventions such as ECT and TMS in the neuropsychiatric population and review novel applications of ECT and TMS
  • Debate options for managing a complex case of treatment resistant depression
  • Explain the principles of MR-guided Focused Ultrasound (MRgFUS) therapy and discuss current diseases that can be effectively treated with MRgFUS
  • Review the history of Gamma Knife's treatment of Trigeminal Neuralgia, describe patient selection criteria for Gamma Knife treatment of Trigeminal Neuralgia and discuss success rates and complication rates for Gamma Knife treatment of Trigeminal Neuralgia
  • Describe examples of signs and symptoms of Trigeminal Neuralgia, discuss treatment options and review examples of a specific workup involved in treatment
  • Discuss the evidence supporting neuropathic back pain for spinal cord stimulation, review outcomes for neuromodulation for back pain and describe emerging technologies and techniques of neuromodulation for back pain
  • Outline the different types of and indications for injections for back pain and discuss the latest recommendations for injection therapies
  • Differentiate between a structural and non-structural spine problem, outline outcomes of surgery for structural problems and discuss lower back pain as a non-structural problem that is not helped with surgery
  • Discuss treatment options for back pain and review examples of a specific workup involved in treatment
  • Describe the neuroanatomy and neurophysiology of the mammalian cerebral cortex and discuss the single neurons in the human medial temporal lobe

Overview
Description & Objectives
Agenda
Faculty
CME Credit
Registration Fees

This course has been cancelled.

Please contact cme@swedish.org for more information.

 

Date:
November 22, 2013
Add to Calendar

Time:
7:15 a.m.-4:30 p.m.

Location:
Seattle Science Foundation
Directions

 

Swedish Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Contact Us

CME@swedish.org

(206) 386-2755